NAD+-Dependent Enzymes at the Endoplasmic Reticulum

Current Topics in Medicinal Chemistry

Volumn 13, Issue 23, 2013, Pages 3001-3010

  Di Girolamo, Maria ^a   Fabrizio, Gaia ^a   Scarpa, Emanuele Salvatore ^a   Di Paola, Simone ^a,b  

^a Laboratorio Angela Valenti dei Fattori Genetici e Ambientali di Rischio Trombotico   (Italy)

^b TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

Author keywords

ADP ribosyltransferase; ARTC; ARTD; Endoplasmic reticulum; Importin 1; NAD; Post translational modification; UPR

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ACTIVATING TRANSCRIPTION FACTOR 6; ADENOSINE TRIPHOSPHATE; CALNEXIN; CALRETICULIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUCOSE REGULATED PROTEIN 78; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; KARYOPHERIN BETA; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 16; NICOTINAMIDE NUCLEOTIDE; NICOTINAMIDE NUCLEOTIDE ADENYLYLTRANSFERASE; NICOTINAMIDE RIBOSIDE; NICOTINIC ACID; PEPTIDES AND PROTEINS; PROTEIN DISULFIDE ISOMERASE; PROTEIN IRE1; PROTEIN PERK; RYANODINE RECEPTOR; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; STRESS ACTIVATED PROTEIN KINASE; TRYPTOPHAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; X BOX BINDING PROTEIN 1;

ADENOSINE DIPHOSPHATE RIBOSYLATION; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CALCIUM HOMEOSTASIS; CANCER THERAPY; CELL MIGRATION; CLINICAL TRIAL (TOPIC); DNA DAMAGE; DOWN REGULATION; ENDOPLASMIC RETICULUM; EPIGENETICS; HUMAN; IMMUNOMODULATION; INFLAMMATION; LIPOGENESIS; NONHUMAN; PEROXISOME; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PROCESSING; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

ANIMALS; ENDOPLASMIC RETICULUM; HUMANS; NAD; POLY(ADP-RIBOSE) POLYMERASES;

EID: 84888984794     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/15680266113136660214     Document Type: Article

References (136)

1. Ziegler, M. New functions of a long-known molecule. Emerging roles of NAD in cellular signaling. Eur. J. Biochem., 2000, 267(6), 1550-64.
2. Berger, F.; Ramirez-Hernandez, M. H.; Ziegler, M. The new life of a centenarian: signalling functions of NAD(P). Trends. Biochem. Sci., 2004, 29(3), 111-8.
3. Seman, M.; Adriouch, S.; Scheuplein, F.; Krebs, C.; Freese, D.; Glowacki, G.; Deterre, P.; Haag, F.; Koch-Nolte, F. NAD-induced T cell death: ADP-ribosylation of cell surface proteins by ART2 activates the cytolytic P2X7 purinoceptor. Immunity, 2003, 19(4), 571-82.
4. Schreiber, V.; Dantzer, F.; Ame, J. C.; de Murcia, G. Poly(ADPribose): novel functions for an old molecule. Nat. Rev. Mol. Cell. Biol., 2006, 7(7), 517-28.
5. Di Girolamo, M.; Dani, N.; Stilla, A.; Corda, D. Physiological relevance of the endogenous mono-ADP-ribosylation of cellular proteins. FEBS J., 2005, 272(18), 4565-75.
6. Hottiger, M. O.; Hassa, P. O.; Luscher, B.; Schuler, H.; Koch-Nolte, F. Toward a unified nomenclature for mammalian ADPribosyltransferases. Trends Biochem. Sci., 2010, 35(4), 208-19.
7. Denu, J. M. The Sir 2 family of protein deacetylases. Curr. Opin. Chem. Biol., 2005, 9(5), 431-40.
8. +. Mol. Cell Biochem., 1994, 138(1-2), 229-35.
9. + glycohydrolase. Biochem. J., 1998, 330(Pt 3), 1383-90.
10. + and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts. J. Biol. Chem., 2001, 276(51), 48300-8.
11. Rongvaux, A.; Andris, F.; Van Gool, F.; Leo, O. Reconstructing eukaryotic NAD metabolism. Bioessays, 2003, 25(7), 683-90.
12. Schuber, F.; Lund, F. E. Structure and enzymology of ADP-ribosyl cyclases: conserved enzymes that produce multiple calcium mobilizing metabolites. Curr. Mol. Med., 2004, 4(3), 249-61.
13. Malavasi, F.; Deaglio, S.; Funaro, A.; Ferrero, E.; Horenstein, A. L.; Ortolan, E.; Vaisitti, T.; Aydin, S. Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol. Rev., 2008, 88(3), 841-86.
14. Zatman, L. J.; Kaplan, N. O.; Colowick, S. P. Inhibition of spleen diphosphopyridine nucleotidase by nicotinamide, an exchange reaction. J. Biol. Chem., 1953, 200(1), 197-212.
15. + homeostasis in man. Cell Mol. Life Sci., 2004, 61(1), 19-34.
16. Preiss, J.; Handler, P. Biosynthesis of diphosphopyridine nucleotide. I. Identification of intermediates. J. Biol. Chem., 1958, 233(2), 488-92.
17. + in fungi and humans. Cell, 2004, 117(4), 495-502.
18. Berger, F.; Lau, C.; Dahlmann, M.; Ziegler, M. Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J. Biol. Chem., 2005, 280(43), 36334-41.
19. Milde, S.; Gilley, J.; Coleman, M. P. Subcellular localization determines the stability and axon protective capacity of axon survival factor Nmnat2. PLoS Biol., 2013, 11(4), e1001539.
20. Berger, F.; Lau, C.; Ziegler, M. Regulation of poly(ADP-ribose) polymerase 1 activity by the phosphorylation state of the nuclear NAD biosynthetic enzyme NMN adenylyl transferase 1. Proc. Natl. Acad. Sci. U S A, 2007, 104(10), 3765-70.
21. Lombard, D. B.; Alt, F. W.; Cheng, H. L.; Bunkenborg, J.; Streeper, R. S.; Mostoslavsky, R.; Kim, J.; Yancopoulos, G.; Valenzuela, D.; Murphy, A.; Yang, Y.; Chen, Y.; Hirschey, M. D.; Bronson, R. T.; Haigis, M.; Guarente, L. P.; Farese, R. V. Jr.; Weissman, S.; Verdin, E.; Schwer, B. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol., 2007, 27(24), 8807-14.
22. Haigis, M. C.; Mostoslavsky, R.; Haigis, K. M.; Fahie, K.; Christodoulou, D. C.; Murphy, A. J.; Valenzuela, D. M.; Yancopoulos, G. D.; Karow, M.; Blander, G.; Wolberger, C.; Prolla, T. A.; Weindruch, R.; Alt, F. W.; Guarente, L. SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell, 2006, 126(5), 941-54.
23. Du, J.; Zhou, Y.; Su, X.; Yu, J. J.; Khan, S.; Jiang, H.; Kim, J.; Woo, J.; Kim, J. H.; Choi, B. H.; He, B.; Chen, W.; Zhang, S.; Cerione, R. A.; Auwerx, J.; Hao, Q.; Lin, H. Sirt5 is a NADdependent protein lysine demalonylase and desuccinylase. Science, 2011, 334(6057), 806-9.
24. Mayer, P. R.; Huang, N.; Dewey, C. M.; Dries, D. R.; Zhang, H.; Yu, G. Expression, localization, and biochemical characterization of nicotinamide mononucleotide adenylyltransferase 2. J. Biol. Chem., 2010, 285(51), 40387-96.
25. Dolle, C.; Niere, M.; Lohndal, E.; Ziegler, M. Visualization of subcellular NAD pools and intra-organellar protein localization by poly-ADP-ribose formation. Cell. Mol. Life Sci., 2010, 67(3), 433-43.
26. +. Biochem. J., 2012, 443(1), 241-7.
27. Ma, C.; Agrawal, G.; Subramani, S. Peroxisome assembly: matrix and membrane protein biogenesis. J. Cell. Biol., 2011, 193(1), 7-16.
28. Ozols, J. Isolation and the complete amino acid sequence of lumenal endoplasmic reticulum glucose-6-phosphate dehydrogenase. Proc. Natl. Acad. Sci. U S A, 1993, 90(11), 5302-6.
29. Rogoff, D.; Black, K.; McMillan, D. R.; White, P. C. Contribution of hexose-6-phosphate dehydrogenase to NADPH content and redox environment in the endoplasmic reticulum. Redox. Rep., 2010, 15(2), 64-70.
30. Baumann, O.; Walz, B. Endoplasmic reticulum of animal cells and its organization into structural and functional domains. Int. Rev. Cytol., 2001, 205, 149-214.
31. Voeltz, G. K.; Rolls, M. M.; Rapoport, T. A. Structural organization of the endoplasmic reticulum. EMBO Rep., 2002, 3(10), 944-50.
32. de Brito, O. M.; Scorrano, L. An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship. Embo J., 2010, 29(16), 2715-23.
33. + store: a view from the lumen. Trends Biochem. Sci., 1998, 23(1), 10-4.
34. Webster, M.; Witkin, K. L.; Cohen-Fix, O. Sizing up the nucleus: nuclear shape, size and nuclear-envelope assembly. J. Cell. Sci., 2009, 122(Pt 10), 1477-86.
35. Fagone, P.; Jackowski, S. Membrane phospholipid synthesis and endoplasmic reticulum function. J. Lipid Res., 2009, 50 Suppl, S311-6.
36. + fluxes. Gen. Physiol. Biophys., 2012, 31(4), 401-8.
37. Aebi, M.; Bernasconi, R.; Clerc, S.; Molinari, M. N-glycan structures: recognition and processing in the ER. Trends Biochem. Sci., 2010, 35(2), 74-82.
38. Brodsky, J. L. Cleaning up: ER-associated degradation to the rescue. Cell, 2012, 151(6), 1163-7.
39. Smith, M. H.; Ploegh, H. L.; Weissman, J. S. Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science, 2011, 334(6059), 1086-90.
40. Vembar, S. S.; Brodsky, J. L. One step at a time: endoplasmic reticulum-associated degradation. Nat. Rev. Mol. Cell. Biol., 2008, 9(12), 944-57.
41. Merksamer, P. I.; Papa, F. R. The UPR and cell fate at a glance. J. Cell. Sci., 2010, 123(Pt 7), 1003-6.
42. Walter, P.; Ron, D. The unfolded protein response: from stress pathway to homeostatic regulation. Science, 2011, 334(6059), 1081-6.
43. Ron, D.; Walter, P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell. Biol., 2007, 8(7), 519-29.
44. Bertolotti, A.; Zhang, Y.; Hendershot, L. M.; Harding, H. P.; Ron, D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol., 2000, 2(6), 326-32.
45. Walter, P.; Ron, D. The unfolded protein response: from stress pathway to homeostatic regulation. Science, 2011, 334(6059), 1081-6.
46. Harding, H. P.; Zhang, Y.; Ron, D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature, 1999, 397(6716), 271-4.
47. Harding, H. P.; Zhang, Y.; Bertolotti, A.; Zeng, H.; Ron, D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell., 2000, 5(5), 897-904.
48. Brewer, J. W.; Diehl, J. A. PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proc. Natl. Acad. Sci. U S A, 2000, 97(23), 12625-30.
49. Shen, J.; Chen, X.; Hendershot, L.; Prywes, R. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev. Cell., 2002, 3(1), 99-111.
50. Yoshida, H.; Matsui, T.; Yamamoto, A.; Okada, T.; Mori, K. XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell, 2001, 107(7), 881-91.
51. Calfon, M.; Zeng, H.; Urano, F.; Till, J. H.; Hubbard, S. R.; Harding, H. P.; Clark, S. G.; Ron, D. IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA. Nature, 2002, 415(6867), 92-6.
52. Haze, K.; Yoshida, H.; Yanagi, H.; Yura, T.; Mori, K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol. Biol. Cell, 1999, 10(11), 3787-99.
53. Ma, Y.; Brewer, J. W.; Diehl, J. A.; Hendershot, L. M. Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response. J. Mol. Biol., 2002, 318(5), 1351-65.
54. Wu, J.; Rutkowski, D. T.; Dubois, M.; Swathirajan, J.; Saunders, T.; Wang, J.; Song, B.; Yau, G. D.; Kaufman, R. J. ATF6alpha optimizes long-term endoplasmic reticulum function to protect cells from chronic stress. Dev. Cell, 2007, 13(3), 351-64.
55. Yamamoto, K.; Sato, T.; Matsui, T.; Sato, M.; Okada, T.; Yoshida, H.; Harada, A.; Mori, K. Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6ooand XBP1. Dev. Cell, 2007, 13(3), 365-76.
56. Marciniak, S. J.; Yun, C. Y.; Oyadomari, S.; Novoa, I.; Zhang, Y.; Jungreis, R.; Nagata, K.; Harding, H. P.; Ron, D. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes. Dev., 2004, 18(24), 3066-77.
57. Urano, F.; Wang, X.; Bertolotti, A.; Zhang, Y.; Chung, P.; Harding, H. P.; Ron, D. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science, 2000, 287(5453), 664-6.
58. Nishitoh, H.; Matsuzawa, A.; Tobiume, K.; Saegusa, K.; Takeda, K.; Inoue, K.; Hori, S.; Kakizuka, A.; Ichijo, H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev., 2002, 16(11), 1345-55.
59. Haas, I. G. BiP (GRP78), an essential hsp70 resident protein in the endoplasmic reticulum. Experientia, 1994, 50(11-12), 1012-20.
60. Schroder, M.; Kaufman, R. J. The mammalian unfolded protein response. Annu. Rev. Biochem., 2005, 74, 739-89.
61. Laitusis, A. L.; Brostrom, M. A.; Brostrom, C. O. The dynamic role of GRP78/BiP in the coordination of mRNA translation with protein processing. J. Biol. Chem., 1999, 274(1), 486-93.
62. Ledford, B. E.; Leno, G. H. ADP-ribosylation of the molecular chaperone GRP78/BiP. Mol. Cell. Biochem., 1994, 138(1-2), 141-8.
63. Freiden, P. J.; Gaut, J. R.; Hendershot, L. M. Interconversion of three differentially modified and assembled forms of BiP. Embo J., 1992, 11(1), 63-70.
64. Staddon, J. M.; Bouzyk, M. M.; Rozengurt, E. Interconversion of GRP78/BiP. A novel event in the action of Pasteurella multocida toxin, bombesin, and platelet-derived growth factor. J. Biol. Chem., 1992, 267(35), 25239-45.
65. Leno, G. H.; Ledford, B. E. Reversible ADP-ribosylation of the 78 kDa glucose-regulated protein. FEBS Lett., 1990, 276(1-2), 29-33.
66. Leno, G. H.; Ledford, B. E. ADP-ribosylation of the 78-kDa glucose-regulated protein during nutritional stress. Eur. J. Biochem., 1989, 186(1-2), 205-11.
67. Chambers, J. E.; Petrova, K.; Tomba, G.; Vendruscolo, M.; Ron, D. ADP-ribosylation adapts an ER chaperone response to short-term fluctuations in unfolded protein load. J. Cell. Biol., 2012, 198(3), 371-85.
68. Liszt, G.; Ford, E.; Kurtev, M.; Guarente, L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem., 2005, 280(22), 21313-20.
69. Feldman, J. L.; Baeza, J.; Denu, J. M. Activation of the Protein Deacetylase SIRT6 by Long-chain Fatty Acids and Widespread Deacylation by Mammalian Sirtuins. J. Biol. Chem., 2013, 288(43), 31350-6.
70. Krueger, K. M.; Barbieri, J. T. The family of bacterial ADPribosylating exotoxins. Clin. Microbiol. Rev., 1995, 8(1), 34-47.
71. Glowacki, G.; Braren, R.; Firner, K.; Nissen, M.; Kuhl, M.; Reche, P.; Bazan, F.; Cetkovic-Cvrlje, M.; Leiter, E.; Haag, F.; Koch-Nolte, F. The family of toxin-related ecto-ADP-ribosyltransferases in humans and the mouse. Protein Sci., 2002, 11(7), 1657-70.
72. Okazaki, I. J.; Moss, J. Characterization of glycosylphosphatidylinositiol-anchored, secreted, and intracellular vertebrate mono-ADP-ribosyltransferases. Annu. Rev. Nutr., 1999, 19, 485-509.
73. Stilla, A.; Di Paola, S.; Dani, N.; Krebs, C.; Arrizza, A.; Corda, D.; Haag, F.; Koch-Nolte, F.; Di Girolamo, M. Characterisation of a novel glycosylphosphatidylinositol-anchored mono-ADPribosyltransferase isoform in ovary cells. Eur. J. Cell. Biol., 2011, 90(8), 665-77.
74. Domenighini, M.; Rappuoli, R. Three conserved consensus sequences identify the NAD-binding site of ADP-ribosylating enzymes, expressed by eukaryotes, bacteria and T-even bacteriophages. Mol. Microbiol., 1996, 21(4), 667-74.
75. Domenighini, M.; Magagnoli, C.; Pizza, M.; Rappuoli, R. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins. Mol. Microbiol., 1994, 14(1), 41-50.
76. Friedrich, M.; Grahnert, A.; Paasch, U.; Tannapfel, A.; Koch-Nolte, F.; Hauschildt, S. Expression of toxin-related human mono-ADP-ribosyltransferase 3 in human testes. Asian J. Androl., 2006, 8(3), 281-7.
77. Koch-Nolte, F.; Haag, F.; Braren, R.; Kuhl, M.; Hoovers, J.; Balasubramanian, S.; Bazan, F.; Thiele, H. G. Two novel human members of an emerging mammalian gene family related to mono-ADP-ribosylating bacterial toxins. Genomics, 1997, 39(3), 370-6.
78. Paone, G.; Wada, A.; Stevens, L. A.; Matin, A.; Hirayama, T.; Levine, R. L.; Moss, J. ADP ribosylation of human neutrophil peptide-1 regulates its biological properties. Proc. Natl. Acad. Sci. U S A, 2002, 99(12), 8231-5.
79. Zolkiewska, A.; Moss, J. Integrin alpha 7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells. J. Biol. Chem., 1993, 268(34), 25273-6.
80. Okazaki, I. J.; Moss, J. Glycosylphosphatidylinositol-anchored and secretory isoforms of mono-ADP-ribosyltransferases. J. Biol. Chem., 1998, 273(37), 23617-20.
81. Corda, D.; Di Girolamo, M. Functional aspects of protein mono-ADP-ribosylation. EMBO J., 2003, 22(9), 1953-8.
82. Corda, D.; Di Girolamo, M. Mono-ADP-ribosylation: a tool for modulating immune response and cell signaling. Sci. STKE, 2002(163), PE53.
83. Kim, C.; Slavinskaya, Z.; Merrill, A. R.; Kaufmann, S. H. Human alpha-defensins neutralize toxins of the mono-ADPribosyltransferase family. Biochem. J., 2006, 399(2), 225-9.
84. Seman, M.; Adriouch, S.; Haag, F.; Koch-Nolte, F. Ecto-ADPribosyltransferases (ARTs): emerging actors in cell communication and signaling. Curr. Med. Chem., 2004, 11(7), 857-72.
85. Karras, G. I.; Kustatscher, G.; Buhecha, H. R.; Allen, M. D.; Pugieux, C.; Sait, F.; Bycroft, M.; Ladurner, A. G. The macro domain is an ADP-ribose binding module. Embo J., 2005, 24(11), 1911-20.
86. Dani, N.; Stilla, A.; Marchegiani, A.; Tamburro, A.; Till, S.; Ladurner, A. G.; Corda, D.; Di Girolamo, M. Combining affinity purification by ADP-ribose-binding macro domains with mass spectrometry to define the mammalian ADP-ribosyl proteome. Proc. Natl. Acad. Sci. U S A, 2009, 106(11), 4243-8.
87. Takada, T.; Iida, K.; Moss, J. Cloning and site-directed mutagenesis of human ADP-ribosylarginine hydrolase. J. Biol. Chem., 1993, 268(24), 17837-43.
88. Lin, W.; Ame, J. C.; Aboul-Ela, N.; Jacobson, E. L.; Jacobson, M. K. Isolation and characterization of the cDNA encoding bovine poly(ADP-ribose) glycohydrolase. J. Biol. Chem., 1997, 272(18), 11895-901.
89. Niere, M.; Mashimo, M.; Agledal, L.; Doelle, C.; Kasamatsu, A.; Kato, J.; Moss, J.; Ziegler, M. ADP-Ribosylhydrolase 3 (ARH3), not Poly-ADP-Ribose Glycohydrolase (PARG) Isoforms, are Responsible for Degradation of Mitochondrial Matrix-Associated Poly-ADP-Ribose. J. Biol. Chem., 2012, 287(20), 16088-16102.
90. Slade, D.; Dunstan, M. S.; Barkauskaite, E.; Weston, R.; Lafite, P.; Dixon, N.; Ahel, M.; Leys, D.; Ahel, I. The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase. Nature, 2011, 477(7366), 616-20.
91. Ono, T.; Kasamatsu, A.; Oka, S.; Moss, J. The 39-kDa poly(ADPribose) glycohydrolase ARH3 hydrolyzes O-acetyl-ADP-ribose, a product of the Sir2 family of acetyl-histone deacetylases. Proc. Natl. Acad. Sci. U S A, 2006, 103(45), 16687-91.
92. Feijs, K. L.; Verheugd, P.; Luscher, B. Expanding functions of intracellular resident mono-ADP-ribosylation in cell physiology. Febs J., 2013, 280(15), 3519-29.
93. Rosenthal, F.; Feijs, K. L.; Frugier, E.; Bonalli, M.; Forst, A. H.; Imhof, R.; Winkler, H. C.; Fischer, D.; Caflisch, A.; Hassa, P. O.; Luscher, B.; Hottiger, M. O. Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases. Nat. Struct. Mol. Biol., 2013, 20(4), 502-7.
94. Ame, J. C.; Spenlehauer, C.; de Murcia, G. The PARP superfamily. Bioessays, 2004, 26(8), 882-93.
95. Gibson, B. A.; Kraus, W. L. New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs. Nat. Rev. Mol. Cell. Biol., 2012, 13(7), 411-24.
96. Miwa, M.; Masutani, M. Poly-ADP-ribosylation and cancer. Cancer Sci., 2007, 98(10), 1528-35.
97. Boehler, C.; Dantzer, F. PARP-3, a DNA-dependent PARP with emerging roles in double-strand break repair and mitotic progression. Cell Cycle, 2011, 10(7), 1023-4.
98. Chang, P.; Coughlin, M.; Mitchison, T. J. Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function. Nat. Cell Biol., 2005, 7(11), 1133-9.
99. Kanai, M.; Tong, W. M.; Sugihara, E.; Wang, Z. Q.; Fukasawa, K.; Miwa, M. Involvement of poly(ADP-Ribose) polymerase 1 and poly(ADP-Ribosyl)ation in regulation of centrosome function. Mol. Cell. Biol., 2003, 23(7), 2451-62.
100. Yu, M.; Schreek, S.; Cerni, C.; Schamberger, C.; Lesniewicz, K.; Poreba, E.; Vervoorts, J.; Walsemann, G.; Grotzinger, J.; Kremmer, E.; Mehraein, Y.; Mertsching, J.; Kraft, R.; Austen, M.; Luscher-Firzlaff, J.; Luscher, B. PARP-10, a novel Myc-interacting protein with poly(ADP-ribose) polymerase activity, inhibits transformation. Oncogene, 2005, 24(12), 1982-93.
101. Feijs, K. L.; Kleine, H.; Braczynski, A.; Forst, A. H.; Herzog, N.; Verheugd, P.; Linzen, U.; Kremmer, E.; Luscher, B. ARTD10 substrate identification on protein microarrays: regulation of GSK3i by mono-ADP-ribosylation. Cell Commun. Signal., 2013, 11(1), 5.
102. Wu, D.; Pan, W. GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem. Sci., 2010, 35(3), 161-8.
103. Kleine, H.; Poreba, E.; Lesniewicz, K.; Hassa, P. O.; Hottiger, M. O.; Litchfield, D. W.; Shilton, B. H.; Luscher, B. Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol. Cell, 2008, 32(1), 57-69.
104. Di Paola, S.; Micaroni, M.; Di Tullio, G.; Buccione, R.; Di Girolamo, M. PARP16/ARTD15 Is a Novel Endoplasmic-Reticulum-Associated Mono-ADP-ribosyltransferase that interacts with, and modifies Karyopherinm1. PLoS ONE, 2012, 7(6), e37352.
105. Goenka, S.; Boothby, M. Selective potentiation of Stat-dependent gene expression by collaborator of Stat6 (CoaSt6), a transcriptional cofactor. Proc. Natl. Acad. Sci. U S A, 2006, 103(11), 4210-5.
106. Scarpa, E. S.; Fabrizio, G.; Di Girolamo, M. A role of intracellular mono-ADP-ribosylation in cancer biology. Febs J., 2013, 280(15), 3551-62.
107. Jwa, M.; Chang, P. PARP16 is a tail-anchored endoplasmic reticulum protein required for the PERK-and IRE1alpha-mediated unfolded protein response. Nat. Cell Biol., 2012, 14(11), 1223-30.
108. Fried, H.; Kutay, U. Nucleocytoplasmic transport: taking an inventory. Cell Mol Life Sci, 2003, 60(8), 1659-88.
109. Conti, E.; Izaurralde, E. Nucleocytoplasmic transport enters the atomic age. Curr. Opin. Cell Biol., 2001, 13(3), 310-9.
110. Gorlich, D.; Prehn, S.; Laskey, R. A.; Hartmann, E. Isolation of a protein that is essential for the first step of nuclear protein import. Cell, 1994, 79(5), 767-78.
111. Harel, A.; Forbes, D. J. Importin beta: conducting a much larger cellular symphony. Mol. Cell, 2004, 16(3), 319-30.
112. Cingolani, G.; Petosa, C.; Weis, K.; Muller, C. W. Structure of importin-beta bound to the IBB domain of importin-alpha. Nature, 1999, 399(6733), 221-9.
113. Gorlich, D.; Kostka, S.; Kraft, R.; Dingwall, C.; Laskey, R. A.; Hartmann, E.; Prehn, S. Two different subunits of importin cooperate to recognize nuclear localization signals and bind them to the nuclear envelope. Curr. Biol., 1995, 5(4), 383-92.
114. Gorlich, D.; Laskey, R. A. Roles of importin in nuclear protein import. Cold Spring Harb. Symp. Quant. Biol., 1995, 60, 695-9.
115. Yashiroda, Y.; Yoshida, M. Nucleo-cytoplasmic transport of proteins as a target for therapeutic drugs. Curr. Med. Chem., 2003, 10(9), 741-8.
116. Poon, I. K.; Jans, D. A. Regulation of nuclear transport: central role in development and transformation? Traffic, 2005, 6(3), 173-86.
117. Davis, J. R.; Kakar, M.; Lim, C. S. Controlling protein compartmentalization to overcome disease. Pharm. Res., 2007, 24(1), 17-27.
118. Hubbard, S. C.; Ivatt, R. J. Synthesis and processing of asparaginelinked oligosaccharides. Annu. Rev. Biochem., 1981, 50, 555-83.
119. Fewell, S. W.; Travers, K. J.; Weissman, J. S.; Brodsky, J. L. The action of molecular chaperones in the early secretory pathway. Annu. Rev. Genet., 2001, 35, 149-91.
120. Zhang, K.; Kaufman, R. J. From endoplasmic-reticulum stress to the inflammatory response. Nature, 2008, 454(7203), 455-62.
121. Zhong, Y.; Wang, Y.; Yang, H.; Ballar, P.; Lee, J. G.; Ye, Y.; Monteiro, M. J.; Fang, S. ImportinMMInteracts with the Endoplasmic Reticulum-associated Degradation Machinery and Promotes Ubiq uitination and Degradation of Mutant u1-Antitrypsin. J. Biol. Chem., 2011, 286(39), 33921-30.
122. Quinones, Q. J.; de Ridder, G. G.; Pizzo, S. V. GRP78: a chaperone with diverse roles beyond the endoplasmic reticulum. Histol. Histopathol., 2008, 23(11), 1409-16.
123. Li, J.; Lee, A. S. Stress induction of GRP78/BiP and its role in cancer. Curr. Mol. Med., 2006, 6(1), 45-54.
124. Uramoto, H.; Sugio, K.; Oyama, T.; Nakata, S.; Ono, K.; Yoshimastu, T.; Morita, M.; Yasumoto, K. Expression of endoplasmic reticulum molecular chaperone Grp78 in human lung cancer and its clinical significance. Lung Cancer, 2005, 49(1), 55-62.
125. Zhang, L. H.; Zhang, X. Roles of GRP78 in physiology and cancer. J. Cell. Biochem., 2010, 110(6), 1299-305.
126. Koumenis, C.; Naczki, C.; Koritzinsky, M.; Rastani, S.; Diehl, A.; Sonenberg, N.; Koromilas, A.; Wouters, B. G. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol. Cell. Biol., 2002, 22(21), 7405-16.
127. Bi, M.; Naczki, C.; Koritzinsky, M.; Fels, D.; Blais, J.; Hu, N.; Harding, H.; Novoa, I.; Varia, M.; Raleigh, J.; Scheuner, D.; Kaufman, R. J.; Bell, J.; Ron, D.; Wouters, B. G.; Koumenis, C. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. Embo J., 2005, 24(19), 3470-81.
128. Koong, A. C.; Chauhan, V.; Romero-Ramirez, L. Targeting XBP-1 as a novel anti-cancer strategy. Cancer Biol. Ther., 2006, 5(7), 756-9.
129. Carrasco, D. R.; Sukhdeo, K.; Protopopova, M.; Sinha, R.; Enos, M.; Carrasco, D. E.; Zheng, M.; Mani, M.; Henderson, J.; Pinkus, G. S.; Munshi, N.; Horner, J.; Ivanova, E. V.; Protopopov, A.; Anderson, K. C.; Tonon, G.; DePinho, R. A. The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis. Cancer Cell, 2007, 11(4), 349-60.
130. Orlowski, R. Z. Why Proteasome Inhibitors Cannot ERADicate Multiple Myeloma. Cancer Cell, 2013, 24(3), 275-7.
131. Leung-Hagesteijn, C.; Erdmann, N.; Cheung, G.; Keats, J. J.; Stewart, A. K.; Reece, D. E.; Chung, K. C.; Tiedemann, R. E. Xbp1snegative tumor B cells and pre-plasmablasts mediate therapeutic proteasome inhibitor resistance in multiple myeloma. Cancer Cell, 2013, 24(3), 289-304.
132. Dani, N.; Barbosa, A. J.; Del Rio, A.; Di Girolamo, M. ADPRibosylated Proteins as Old and New Drug Targets for Anticancer Therapy: the Example of ARF6. Curr. Pharm. Des., 2013, 19(4), 624-633.
133. Donadini, A.; Rosano, C.; Felli, L.; Ponassi, M. Human sirtuins: an overview of an emerging drug target in age-related diseases and cancer. Curr. Drug Targets, 2013, 14(6), 653-61.
134. Bruzzone, S.; Parenti, M. D.; Grozio, A.; Ballestrero, A.; Bauer, I.; Del Rio, A.; Nencioni, A. Rejuvenating sirtuins: the rise of a new family of cancer drug targets. Curr. Pharm. Des., 2013, 19(4), 614-23.
135. Andreoli, F.; Barbosa, A. J.; Parenti, M. D.; Del Rio, A. Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives. Curr. Pharm. Des,., 2013, 19(4), 578-613.
136. Karlberg, T.; Thorsell, A. G.; Kallas, A.; Schuler, H. Crystal structure of human ADP-ribose transferase ARTD15/PARP16 reveals a novel putative regulatory domain. J. Biol. Chem., 2012, 287(29), 24077-81.